Hyperinsulinemia acutely increases serum macrophage inhibitory cytokine-1 concentration in anorexia nervosa and obesity

Clinical Endocrinology

Volumn 76, Issue 1, 2012, Pages 46-50

  Karczewska Kupczewska, Monika ^a   Kowalska, Irina ^a   Nikolajuk, Agnieszka ^a   Adamska, Agnieszka ^a   Otziomek, Elzbieta ^a   Gorska, Maria ^a   Straczkowski, Marek ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CHOLESTEROL; GLUCOSE; GROWTH DIFFERENTIATION FACTOR 15; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANOREXIA NERVOSA; ARTICLE; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CELLULAR IMMUNITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADOLESCENT; ADULT; ANOREXIA NERVOSA; FEMALE; GENE EXPRESSION REGULATION; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; HYPERINSULINISM; OBESITY; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 83455228548     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04139.x     Document Type: Article

References (24)

1. Bootcov, M.R., Bauskin, A.R., Valenzuela, S.M., et al. (1977) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proceedings of the National Academy of Sciences of the United States of America, 94, 11514-11519.
2. Ding, Q., Mracek, T., Gonzalez-Muniesa, P., et al. (2009) Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. Endocrinology, 150, 1688-1696.
3. Böttner, M., Suter-Crazzolara, C., Schober, A., et al. (1999) Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues. Cell and Tissue Research, 297, 103-110. (Pubitemid 29313281)
4. Kim, K.S., Baek, S.J., Flake, G.P., et al. (2002) Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue. Gastroenterology, 122, 1388-1398. (Pubitemid 34465181)
5. Zimmers, T.A., Jin, X., Hsiao, E.C., et al. (2005) Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock, 23, 543-548. (Pubitemid 40677428)
6. Mimeault, M., &, Batra, S.K., (2010) Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer. Journal of Cellular Physiology, 224, 626-635.
7. Brown, D.A., Moore, J., Johnen, H., et al. (2007) Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction. Arthritis and Rheumatism, 56, 753-764. (Pubitemid 46399422)
8. Bauskin, A.R., Brown, D.A., Kuffner, T., et al. (2006) Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Research, 66, 4983-4986. (Pubitemid 43852864)
9. Khan, S.Q., Ng, K., Dhillon, O., et al. (2009) Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. European Heart Journal, 30, 1057-1065.
10. Johnen, H., Lin, S., Kuffner, T., et al. (2007) Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nature Medicine, 13, 1333-1340. (Pubitemid 350073601)
11. Dostálová, I., Kaválková, P., Papezová, H., et al. (2010) Association of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: the influence of partial realimentation. Nutrition and Metabolism, 7, 34.
12. Yager, J., &, Anderson, A.E., (2005) Anorexia Nervosa. New England Journal of Medicine, 353, 1481-1488. (Pubitemid 41400922)
13. Dostálová, I., Roubícek, T., Bártlová, M., et al. (2009) Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet. European Journal of Endocrinology, 161, 397-404.
14. Plum, L., Belgardt, B.F., &, Brüning, J.C., (2006) Central insulin action in energy and glucose homeostasis. Journal of Clinical Investigation, 116, 1761-1766. (Pubitemid 44033295)
15. Saad, M.F., Bernaba, B., Hwu, C.M., et al. (2002) Insulin regulates plasma ghrelin concentration. Journal of Clinical Endocrinology and Metabolism, 87, 3997-4000. (Pubitemid 34879561)
16. Karczewska-Kupczewska, M., Straczkowski, M., Adamska, A., et al. (2010) Increased suppression of serum ghrelin concentration by hyperinsulinemia in women with anorexia nervosa. European Journal of Endocrinology, 162, 235-239.
17. DeFronzo, R.A., Tobin, J.D., &, Andres, R., (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology, 237, E214-E223. (Pubitemid 9249478)
18. Kowalska, I., Straczkowski, M., Nikolajuk, A., et al. (2006) Plasma adiponectin concentration and tumor necrosis factor-alpha system activity in lean non-diabetic offspring of type 2 diabetic subjects. European Journal of Endocrinology, 154, 319-324.
19. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419. (Pubitemid 15018832)
20. Li, P.X., Wong, J., Ayed, A., et al. (2000) Placental transforming growth factor beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. Journal of Biological Chemistry, 275, 20127-20135. (Pubitemid 30441624)
21. Tan, M., Wang, Y., Guan, K., et al. (2000) PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway. Proceedings of the National Academy of Sciences of the United States of America, 97, 109-114. (Pubitemid 30055792)
22. Matsui-Hirai, H., Hayashi, T., Yamamoto, S., et al. (2011) Dose-dependent modulatory effects of insulin on glucose-induced endothelial senescence in vitro and in vivo: a relationship between telomeres and nitric oxide. Journal of Pharmacology and Experimental Therapeutics, 337, 591-599.
23. Baek, S.J., Wilson, L.C., Hsi, L.C., et al. (2003) Troglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) ligand, selectively induces the early growth response-1 gene independently of PPARγ. A novel mechanism for its anti-tumorigenic activity. Journal of Biological Chemistry, 278, 5845-5853. (Pubitemid 36800831)
24. Baek, S.J., Wilson, L.C, &, Eling, T.E., (2002) Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis, 23, 425-434. (Pubitemid 34257622)